FUSN — Fusion Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Annual balance sheet for Fusion Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	65.3	222	201	171	234
Net Total Accounts Receivable
Net Total Receivables	0.428	0.794	2.59	1.72	5.47
Prepaid Expenses
Total Other Current Assets
Total Current Assets	66.6	228	212	179	243
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.27	1.97	9.45	10.3	23.9
Long Term Investments
Other Long Term Assets
Total Assets	69.4	311	252	219	286
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	4.27	11.9	12.5	15.1	16.2
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	31.3	16.2	20.8	56.8	63.4
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	38.1	295	231	162	222
Total Liabilities & Shareholders' Equity	69.4	311	252	219	286
Total Common Shares Outstanding